Development of lamivudine liposomes by three-level factorial design approach for optimum entrapment and enhancing tissue targeting

References

• Ahmad, N., et al., 2018a. Impact of ultrasonication techniques on the preparation of novel Amiloride-nanoemulsion used for intranasal delivery in the treatment of epilepsy. Artificial cells, nanomedicine, and biotechnology, 46 (sup3), S192–S207.
   PubMed Web of Science ®Google Scholar
• Ahmad, N., et al., 2018b. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations. Journal of microencapsulation, 35 (4), 327–343.
   PubMed Web of Science ®Google Scholar
• Ahmad, N., et al., 2019a. A novel nanoformulation development of eugenol and their treatment in inflammation and periodontitis. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 27 (6), 778–790.
   PubMed Web of Science ®Google Scholar
• Ahmad, N., et al., 2019b. Preparation of a novel curcumin nanoemulsion by ultrasonication and its comparative effects in wound healing and the treatment of inflammation. RSC advances, 9 (35), 20192–20206.
   PubMed Web of Science ®Google Scholar
• Ahmad, N., et al., 2020. Quantification and evaluations of catechin hydrate polymeric nanoparticles used in brain targeting for the treatment of epilepsy. Pharmaceutics, 12 (3), 203.
   PubMed Web of Science ®Google Scholar
• Alnouti, Y., White, C.A., and Bartlett, M.G., 2004. Determination of lamivudine in plasma, amniotic fluid, and rat tissues by liquid chromatography. Journal of chromatography B., 803 (2), 279–284.
   PubMed Web of Science ®Google Scholar
• Alsarra, I.A., Hamed, A.Y., and Alanazi, F.K., 2008. Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation. Drug delivery, 15 (5), 313–321.
   PubMed Web of Science ®Google Scholar
• Bangham, A.D., Standish, M.M., and Watkins, J.C., 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of molecular biology, 13 (1), 238–252.
   PubMed Web of Science ®Google Scholar
• Batageri, G.V., Jankins, S.A., and Ravis, W.R., 1993. Drug delivery using antibody-liposomes conjugates. Drug development and industrial pharmacy, 19 (16), 2102–2116.
   Web of Science ®Google Scholar
• Bhardwaj, U. and Burgess, D.J., 2010. Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone. International journal of pharmaceutics, 388 (1–2), 181–189.
   PubMed Web of Science ®Google Scholar
• Bothiraja, C., et al., 2018. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform. Artificial cells, nanomedicine, and biotechnology, 46 (sup1), 447–461.
   PubMed Web of Science ®Google Scholar
• Brandl, M., 2001. Liposomes as drug carriers: a technological approach. Biotechnology annual review, 7, 59–85.
   PubMedGoogle Scholar
• Calvagno, M.G., et al., 2007. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. Current drug delivery, 4 (1), 89–101.
   PubMedGoogle Scholar
• De, A. and Venkatesh, D.N., 2012. Design and evaluation of liposomal delivery system for L-Asparaginese. Journal of applied pharmaceutical science, 2 (8), 112–117.
   Google Scholar
• Desormeaux, A., et al., 1994. Antiviral efficacy, intracellular uptake and pharmacokinetics of free and liposome-encapsulated 2’,3’-dideoxyinosine. AIDS, 8, 1545–1553.
   PubMed Web of Science ®Google Scholar
• Desormeaux, A. and Bergeron, M.G., 1998. Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection. Journal of drug targeting, 6 (1), 1–15.
   PubMed Web of Science ®Google Scholar
• Dua, J.S., Rana, A.C., and Bhandari, A.K., 2012. Liposome: methods of preparation and applications. International journal of pharmaceutical research, 3 (2), 14–20.
   Google Scholar
• Dubey, V., et al., 2011. Surface structured liposomes for site specific delivery of an antiviral agent-indinavir. Journal of drug targeting, 19 (4), 258–269.
   PubMed Web of Science ®Google Scholar
• Dusserre, N., et al., 1995. Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics. AIDS (London, England)), 9 (8), 833–841.
   PubMed Web of Science ®Google Scholar
• Embretson, J., et al., 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature, 362 (6418), 359–362.
   PubMed Web of Science ®Google Scholar
• Gaafar, P.M.E., et al., 2014. Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone. Journal of liposome research, 24 (3), 204–215.
   PubMed Web of Science ®Google Scholar
• Ghanbarzadeh, S., Valizadeh, H., and Zakeri-Milani, P., 2013. Application of response surface methodology in development of sirolimus liposomes prepared by thin film hydration technique. BioImpacts : BI, 3 (2), 75–81.
   PubMedGoogle Scholar
• Godbole, M.D. and Mathur, V.B., 2018. Selection of phospholipid and method of formulation for optimum entrapment and release of lamivudine from liposome. Journal of drug delivery and therapeutics, 8 (5–s), 175–183.
   Google Scholar
• Gregoriadis, G., 1991. Overview of liposomes. Journal of antimicrobial chemotherapy., 28 (suppl B), 39–48.
   PubMed Web of Science ®Google Scholar
• Gupta, U. and Jain, N.K., 2010. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. Advanced drug delivery reviews, 62 (4-5), 478–490.
   PubMed Web of Science ®Google Scholar
• Harvie, P., et al., 1995. Lymphoid tissues targeting of liposome-encapsulated 2’,3’-dideoxyinosine. AIDS (London, England)), 9 (7), 701–707.
   PubMed Web of Science ®Google Scholar
• Harvie, P., et al., 1996. Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 20,30-dideoxyinosine. Antimicrobial agents and chemotherapy, 40 (1), 225–229.
   PubMed Web of Science ®Google Scholar
• Jain, S., et al., 2007. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS pharmscitech, 8 (4), 111.
   PubMed Web of Science ®Google Scholar
• Jain, S.K., et al., 2005. Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium. AAPS pharmscitech, 6 (1), E35–41.
   PubMed Web of Science ®Google Scholar
• Kakami, Y., Takeuchi, I., and Makino, K., 2019. Percutaneous immunization with 40-nm antigen-encapsulated elastic liposomes. Colloids and surfaces A: physicochemical and engineering aspects, 566, 128–133.
   Web of Science ®Google Scholar
• Kirby, C., Clarke, J., and Gregoriadis, G., 1980. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. The biochemical journal, 186 (2), 591–598.
   PubMed Web of Science ®Google Scholar
• Kulkarni, S.B., Betageri, G.V., and Singh, M., 1995. Factors affecting microencapsulation of drugs in liposomes. Journal of microencapsulation, 12 (3), 229–246.
   PubMed Web of Science ®Google Scholar
• Lawrence, S.M., et al., 1993. Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge on drug association. Journal of drug targeting, 1 (4), 303–310.
   PubMed Web of Science ®Google Scholar
• Makabi-Panzu, B., et al., 1994. Comparison of cellular accumulation, tissue distribution, and anti-HIV activity of free and liposomal 2’,3’-dideoxycytidine. AIDS research and human retroviruses, 10 (11), 1463–1470.
   PubMed Web of Science ®Google Scholar
• Makino, K., et al., 2003. Effects of liposomal phophatidylserine on phagocytic uptake of liposomes by macrophage-like HL-60RG cells. Colloids and surfaces B: biointerfaces, 29 (4), 277–284.
   Web of Science ®Google Scholar
• Mallipeddi, R. and Rohan, L.C., 2010. Progress in antiretroviral drug delivery using nanotechnology. International journal of nanomedicine, 5, 533–547.
   PubMed Web of Science ®Google Scholar
• Mathai, J.C. and Sitaramam, V., 1987. Preparation of large uni-lamellar liposomes by the ether injection method and evaluation of the physical integrity by osmometry. Biochemical education, 15, 3–9.
   Google Scholar
• McGowan, I., 2008. Rectal microbicides: a new focus for HIV prevention. Sexually transmitted infections, 84 (6), 413–417.
   PubMed Web of Science ®Google Scholar
• Moyle, G., 2000. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity. Clinical therapeutics, 22 (8), 911–936.
   PubMed Web of Science ®Google Scholar
• Nasr, M., et al., 2008. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. Journal of microencapsulation, 25 (7), 499–512.
   PubMed Web of Science ®Google Scholar
• Nayak, A.K. and Pal, D., 2011. Development of pH-sensitive tamarind seed polysaccharide-alginate composite beads for controlled diclofenac sodium delivery using response surface methodology. International journal of biological macromolecules, 49 (4), 784–793.
   PubMed Web of Science ®Google Scholar
• Nayak, A.K., Pal, D., and Santra, K., 2014. Artocarpus heterophyllus L. seed starch-blended gellan gum mucoadhesive beads of metformin HCl. International journal of biological macromolecules, 65, 329–339.
   PubMed Web of Science ®Google Scholar
• Oussoren, C., et al., 1999. Liposomes as carriers of the antiretroviral agent dideoxycytidine-5’-triphosphate. International journal of pharmaceutics, 180 (2), 261–270.
   PubMed Web of Science ®Google Scholar
• Patel, G.M., Shelat, P.K., and Lalwani, A.N., 2017. QbD based development of proliposome of lopinavir for improved oral bioavailability. European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences, 108, 50–61.
   PubMed Web of Science ®Google Scholar
• Poyner, E.A., et al., 1995. A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery. Journal of controlled release, 35 (1), 41–48.
   Web of Science ®Google Scholar
• Ravi, P.R., Ganga, S., and Saha, R.N., 2007. Design and study of lamivudine oral controlled release tablets. AAPS pharmscitech, 8 (4), Article 101.
   Web of Science ®Google Scholar
• Sailor, G., et al., 2015. Formulation and in vitro evaluation of berberine containing liposome optimized by 32 full factorial designs. Journal of applied pharmaceutical science, 5 (7), 23–28.
   Google Scholar
• Schrager, L.K. and D’Souza, M.P., 1998. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA, 280 (1), 67–71.
   PubMed Web of Science ®Google Scholar
• Senior, J.H., 1987. Fate and behaviour of liposomes in vivo: a review of controlling factors. Critical reviews in therapeutic drug carrier systems, 3, 123–193.
   PubMed Web of Science ®Google Scholar
• Shavi, G.V., et al., 2016. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation. Journal of liposome research, 26 (1), 28–46.
   PubMed Web of Science ®Google Scholar
• Shivhare, U.D., et al., 2009. Formulation and evaluation of pentoxyfylline liposome formulation. Digest journal of nanomaterials and biostructures, 4 (4), 857–862.
   Google Scholar
• Srinath, P., Vyas, S.P., and Diwan, P.V., 2000. Preparation and pharmacodynamic evaluation of liposomes of indomethacin. Drug development and industrial pharmacy, 26 (3), 313–321.
   PubMed Web of Science ®Google Scholar
• Stability testing of new drug substances and products Q1A(R2). 2019. ICH harmonised tripartite guideline. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. https://www.ich.org/ [Accessed 26 June].
   Google Scholar
• Sudhakar, B., Krishna, M.C., and Murthy, K.V.R., 2016. Factorial design studies of antiretroviral drug-loaded stealth liposomal injectable: PEGylation, lyophilisation and pharmacokinetic studies. Applied nanoscience, 6 (1), 43–60.
   Web of Science ®Google Scholar
• Vadiei, K.S., et al., 1989. Pharmacokinetic and pharmacodynamic evaluation of liposomal Cyclosporine. International journal of pharmaceutics., 57 (2), 125–131.
   Web of Science ®Google Scholar
• Vyas, S.P. and Sakthivel, T., 1994. Pressurized pack-based liposomes for pulmonary targeting of isoprenaline-development and characterization. Journal of microencapsulation, 11 (4), 373–380.
   PubMed Web of Science ®Google Scholar
• Xu, X., et al., 2012. Application of quality by design to formulation and processing of protein liposomes. International journal of pharmaceutics, 434 (1-2), 349–359.
   PubMed Web of Science ®Google Scholar
• Yuvaraja, K., Das, S.K., and Khanam, J., 2015. Process optimization and characterization of carvedilol solid dispersion with hydroxypropyl-β-cyclodextrin and tartaric acid. Korean journal of chemical engineering, 32 (1), 132–140.
   Web of Science ®Google Scholar
• Zamboni, W.C., 2005. Liposomal, nanoparticle, and conjugated formulations of anticancer agents. Clinical cancer research : an official journal of the American Association for Cancer Research, 11 (23), 8230–8234.
   PubMed Web of Science ®Google Scholar